Giafranco Bellipanni

Dr. Giafranco Bellipanni

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2013 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
VMValentina Malafoglia
Valentina Malafoglia
BBBruce Bryant
Bruce Bryant
WRWilliam Raffaeli
William Raffaeli
Antonio GiordanoAntonio Giordano
Antonio Giordano
GBGiafranco Bellipanni
Giafranco Bellipanni

8 August 2013 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
VMValentina Malafoglia
Valentina Malafoglia
MCMarco Colasanti
Marco Colasanti
WRWilliam Raffaeli
William Raffaeli
DBDarius Balciunas
Darius Balciunas
Antonio GiordanoAntonio Giordano
Antonio Giordano
GBGiafranco Bellipanni
Giafranco Bellipanni

14 September 2013 in BMC Genomics
Verified
Journal Article
Open access
PDF file
JBJorune Balciuniene
Jorune Balciuniene
DNDanielle Nagelberg
Danielle Nagelberg
KWKathleen T Walsh
Kathleen T Walsh
DCDiana Camerota
Diana Camerota
DGDaphné Georlette
Daphné Georlette
DBDarius Balciunas
Darius Balciunas
Background: External development and optical transparency of embryos make zebrafish exceptionally suitable for in vivo insertional mutagenesis using fluorescent proteins to visualize expression patterns of mutated genes. Recently developed Gene Breaking Transposon (GBT) vectors greatly improve the fidelity and mutagenicity of transposon-based gene trap vectors. Results: We constructed and tested a bipartite GBT vector with Gal4-VP16 as the primary gene trap reporter. Our vector also contains a UAS:eGFP cassette for direct detection of gene trap events by fluorescence. To confirm gene trap events, we generated a UAS:mRFP tester line. We screened 270 potential founders and established 41 gene trap lines. Three of our gene trap alleles display homozygous lethal phenotypes ranging from embryonic to late larval: nsf tpl6 , atp1a3a tpl10 and flr tpl19 . Our gene trap cassette is flanked by direct loxP sites, which enabled us to successfully revert nsf tpl6 , atp1a3a tpl10 and flr tpl19 gene trap alleles by injection of Cre mRNA. The UAS:eGFP cassette is flanked by direct FRT sites. It can be readily removed by injection of Flp mRNA for use of our gene trap alleles with other tissue-specific GFP-marked lines. The Gal4-VP16 component of our vector provides two important advantages over other GBT vectors. The first is increased sensitivity, which enabled us to detect previously unnoticed expression of nsf in the pancreas. The second advantage is that all our gene trap lines, including integrations into non-essential genes, can be used as highly specific Gal4 drivers for expression of other transgenes under the control of Gal4 UAS. Conclusions: The Gal4-containing bipartite Gene Breaking Transposon vector presented here retains high specificity for integrations into genes, high mutagenicity and revertibility by Cre. These features, together with utility as highly specific Gal4 drivers, make gene trap mutants presented here especially useful to the research community.

21 October 2014 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
FVFabio Valenti
Fabio Valenti
JIJessica Ibetti
Jessica Ibetti
YKYuko Komiya
Yuko Komiya
MBMelissa Baxter
Melissa Baxter
ALAnna Maria Lucchese
Anna Maria Lucchese
GBGiafranco Bellipanni
Giafranco Bellipanni

3 November 2009 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
GBGiafranco Bellipanni
Giafranco Bellipanni
TMTohru Murakami
Tohru Murakami
EWEric S. Weinberg
Eric S. Weinberg

14 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
CCCarlee Cunningham
Carlee Cunningham
GBGiafranco Bellipanni
Giafranco Bellipanni
RHRaymond Habas
Raymond Habas
DBDarius Balciunas
Darius Balciunas
Two complimentary approaches are widely used to study gene function in zebrafish: induction of genetic mutations, usually using targeted nucleases such as CRISPR/Cas9, and suppression of gene expression, typically using Morpholino oligomers. Neither method is perfect. Morpholinos (MOs) sometimes produce off-target or toxicity-related effects that can be mistaken for true phenotypes. Conversely, genetic mutants can be subject to compensation, or may fail to yield a null phenotype due to leakiness. When discrepancy between mutant and morpholino-induced (morphant) phenotypes is observed, experimental validation of such phenotypes becomes very labor intensive. We have developed a simple genetic method to differentiate between genuine morphant phenotypes and those produced due to off-target effects. We speculated that indels within 5’ untranslated regions would be unlikely to have a significant negative effect on gene expression. Mutations induced within a MO target site would result in a Morpholino-refractive allele thus suppressing true MO phenotypes whilst non-specific phenotypes would remain. We tested this hypothesis on one gene with an exclusively zygotic function,tbx5a, and one gene with strong maternal effect,ctnnb2. We found that indels within the Morpholino binding site are indeed able to suppress both zygotic and maternal morphant phenotypes. We also observed that the ability of such indels to suppress Morpholino phenotypes does depend on the size and the location of the deletion. Nonetheless, mutating the morpholino binding sites in both maternal and zygotic genes can ascertain the specificity of morphant phenotypes.